KMDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kamada Ltd (KMDA) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, refocused strategy, and bullish technical indicators support this decision. The lack of recent negative news or significant insider selling further strengthens the case for investment.
The technical indicators are mixed but lean bullish. The MACD is negatively expanding, which is a bearish signal, but the RSI is neutral at 53.935. The moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading above its pivot level of 8.977, with resistance levels at 9.271 and 9.453. These factors suggest a positive trend in the short term.
Analysts have raised the price target to $13 from $11, maintaining a Buy rating.
The decision to discontinue the Phase 3 trial refocuses the company on its core products, eliminating distractions.
Strong financial performance in Q3 2025, with revenue, net income, EPS, and gross margin all showing significant YoY growth.
The MACD is negatively expanding, indicating potential short-term bearish momentum.
No recent news or significant trading trends to act as immediate positive catalysts.
In Q3 2025, Kamada's revenue increased by 12.63% YoY to $47.01M, net income rose by 37.10% YoY to $5.296M, EPS grew by 28.57% YoY to $0.09, and gross margin improved by 1.82% YoY to 42.04%. These metrics indicate strong growth and profitability.
H.C. Wainwright raised the price target to $13 from $11 and maintained a Buy rating, citing the company's refocused strategy and elimination of distractions from the discontinued trial.
